Intestinal Cell News Volume 7.42 | Nov 5 2021

    0
    37






    2021-11-05 | ICN 7.42


    Intestinal Cell News by STEMCELL Technologies
    Vol. 7.42 – 5 November, 2021
    TOP STORY

    Enteric Glial Cell Heterogeneity Regulates Intestinal Stem Cell Niches

    Scientists defined the regulation of enteric glial cells heterogeneity in homeostasis and chronic inflammatory bowel disease.
    [Cell Stem Cell]

    Abstract

    Explore Antibodies for Epithelial Cell Markers
    PUBLICATIONSRanked by the impact factor of the journal

    Disruption of Autophagy by Increased 5-HT Alters Gut Microbiota and Enhances Susceptibility to Experimental Colitis and Crohn’s Disease

    Factors that lead to the development of impaired autophagy during intestinal inflammation remain largely unexplored. Researchers reported the impact of the interaction between serotonin (5-HT) and autophagy in colitis in mouse and human studies.
    [Science Advances]

    Full Article

    Genome-Wide Profiling in Colorectal Cancer Identifies PHF19 and TBC1D16 as Oncogenic Super Enhancers

    The authors sequenced 73 pairs of colorectal cancer tissues and generated 147 H3K27ac ChIP-Seq, 144 RNA-Seq, 147 whole genome sequencing and 86 H3K4me3 ChIP-Seq samples.
    [Nature Communications]

    Full Article

    Akt-Mediated Ephexin1–Ras Interaction Promotes Oncogenic Ras Signaling and Colorectal and Lung Cancer Cell Proliferation

    Ephexin1 was reported to be highly upregulated by oncogenic Ras, but the functional consequences of this remain poorly understood. Investigators showed that Ephexin1 was highly expressed in colorectal cancer and lung cancer patient tissues.
    [Cell Death & Disease]

    Full Article

    A Stem Cell Marker KLF5 Regulates CCAT1 via Three-Dimensional Genome Structure in Colorectal Cancer Cells

    Scientists explicated a regulatory mechanism of the KLF5 gene product from a view of three-dimensional genome structure in colorectal cancer.
    [British Journal of Cancer]

    Full Article

    Decreased Expression of ATF3, Orchestrated by β-Catenin/TCF3, miR-17-5p and HOXA11-AS, Promoted Gastric Cancer Progression via Increased β-Catenin and CEMIP

    The mechanisms underlying the abnormal expression of ATF3 and its biological function in gastric cancer (GC) have not been well investigated. Researchers reported ATF3 as one of the key regulators of GC development and progression.
    [Experimental and Molecular Medicine]

    Full Article

    Tricholoma matsutake-Derived Peptide WFNNAGP Protects against DSS-Induced Colitis by Ameliorating Oxidative Stress and Intestinal Barrier Dysfunction

    The authors investigated the mechanisms through which the Tricholoma matsutake-derived peptide, WFNNAGP, exerted protective effects on the inflammatory response and oxidative stress in a dextran sodium sulfate (DSS)-induced IBD mouse model.
    [Food & Function]

    AbstractGraphical Abstract

    Hsp70-Containing Extracellular Vesicles Are Capable of Activating of Adaptive Immunity in Models of Mouse Melanoma and Colon Carcinoma

    To study Hsp70 forms released from cells, scientists employed an assay consisting of two affinity chromatography methods. Hsp70 content in culture medium and extracellular vesicles was measured with the aid of ELISA.
    [Scientific Reports]

    Full Article

    Diosmin in Combination with Naringenin Enhances Apoptosis in Colon Cancer Cells

    The combined effect of diosmin and naringenin in colon cancer cell lines HCT116 and SW480 were assessed by targeting apoptosis and inflammatory pathways.
    [Oncology Reports]

    Abstract

    Explore virtual support and resources to stay productive and connected with your field.
    REVIEWS

    An Update on FMT for the Treatment of Gastrointestinal Diseases

    Studies are continuing to explore the role of fecal microbiota transplantation (FMT) for many other conditions, including Crohn’s disease, functional gut disorders, metabolic syndrome, modulating responses to chemotherapy, eradication of multidrug resistant organisms, and the gut-brain axis.
    [Journal of Gastroenterology and Hepatology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Ironwood
    Pharmaceuticals Expands Pipeline by Signing an Option Agreement to Acquire an Exclusive License with COUR Pharmaceuticals to Develop and Commercialize CNP-104 for the Treatment of Primary Biliary Cholangitis in the US

    Ironwood Pharmaceuticals, Inc. announced that it is expanding its pipeline by entering into a collaboration and license option agreement with COUR Pharmaceutical Development Company, Inc.
    [Ironwood Pharmaceuticals, Inc.]

    Press Release

    FEATURED EVENT

    Microbiome Interactions in Health and Disease

    October 13 – 15, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Intestinal Homeostasis

    University of North Dakota – Grand Forks, North Dakota, United States

    Research Technician – Regeneration

    Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States

    Senior Researcher – Cancer Progression and Metastasis

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Postdoctoral Fellow – Inflammatory Bowel Diseases

    Brigham and Women’s Hospital and Harvard Medical School – Boston, Massachusetts, United States

    Assistant Professor – Cancer Research

    University of Manitoba – Winnipeg, Manitoba, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter